After successful IPO, Quintiles plots 400 job cuts

Global CRO Quintiles ($Q) is planning to slash 400 jobs this year, the company disclosed in a regulatory filing, primarily from its product development and healthcare services departments. The cutbacks make up just about 1.5% of the CRO's global workforce, the News-Observer notes, and a company spokesman told the paper that Quintiles is recruiting to fill about 900 positions around the world. Filing | Story

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

Aetion has raised $50 million so far, and it plans to enhance its platform to support more complex therapeutic areas and expand its team.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.